NFE2L2 and neoplasm: Therefore, tumor cells develop strategies to restrain ROS production to tolerable levels by activating endogenous antioxidant systems such transcription factor NRF2, the master regulator of redox metabolism [20,21], as well as many other cytoprotective functions related to metabolic reprogramming that contribute to cell proliferation in cooperation with other oncogenic pathways [22,23].